Raghuraman Kannan

April 12, 2026

Hashemi, Kannan inducted into AIMBE College of Fellows

Election is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top 2% of engineers in these fields.

Dec. 10, 2025

Mizzou Engineering professor named 2025 NAI Fellow

Raghuraman Kannan is among 169 researchers receiving the prestigious honor from the National Academy of Inventors this year.

Sep. 15, 2025

Mizzou Engineering faculty named Curators’ Distinguished Professors

Sheila Grant and Raghuraman Kannan have received the highest honor bestowed by the University of Missouri System.

July 7, 2025

Study: Why some lung cancer treatments stop working — and possible fixes

University of Missouri scientists discover a hidden "molecular seesaw" behind drug resistance in certain types of lung cancer, offering hope for more effective therapies.

Jan. 4, 2023

Department of Chemical and Biomedical Engineering name change reflects research focus

Mizzou Engineering will put more focus on research and innovations around chemical and biomedical innovations in the coming years.

Oct. 18, 2022

Reversing drug resistance in lung cancer

By Eric Stann | MU News Burea When someone is diagnosed with non-small cell lung cancer — one of two main forms of lung cancer — there is a 70-80% chance that after 14 months the cancer will develop a resistance to the drug therapy originally given to fight it. If that happens, there aren’t many treatment options currently available. That’s why Raghuraman Kannan, the Michael J. and Sharon R. Bukstein Chair in Cancer Research in the University of Missouri School of Medicine, is determined to find a solution. “We want to find out why patients…